Cargando…
Management of Coronavirus Disease 2019 Patients With Lung Cancer: Experience From a Thoracic Oncology Center
BACKGROUND: Cancer patients appear to be at a higher risk of complications from coronavirus disease 2019 (COVID-19). Specific data related to lung cancer (LC) patient management, active treatment, and/or recent diagnosis are still very limited. Here, we aimed to investigate the clinical presentation...
Autores principales: | Coelho, David Barros, Santos, Vanessa, Araújo, David, Bastos, Hélder Novais, Magalhães, Adriana, Hespanhol, Venceslau, Queiroga, Henrique, Cruz-Martins, Natália, Fernandes, Maria Gabriela O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339998/ https://www.ncbi.nlm.nih.gov/pubmed/34368223 http://dx.doi.org/10.3389/fmolb.2021.639676 |
Ejemplares similares
-
P09.35 COVID-19 in Patients with Lung Cancer – Experience from a Thoracic Oncology Center
por: Coelho, D., et al.
Publicado: (2021) -
Resistance Profile of Osimertinib in Pre-treated Patients With EGFR T790M-Mutated Non-small Cell Lung Cancer
por: Fernandes, Maria Gabriela O., et al.
Publicado: (2021) -
Role of Bronchoscopic Techniques in the Diagnosis of Thoracic Sarcoidosis
por: Pedro, Cecília, et al.
Publicado: (2019) -
Standard operating procedures for biobank in oncology
por: Bonizzi, Giuseppina, et al.
Publicado: (2022) -
Molecular Diagnostics in Clinical Oncology
por: Sokolenko, Anna P., et al.
Publicado: (2018)